Category: Vaccines
Oceania Vaccines
-
Temperature-controlled Packaging for Pharmaceutical Market Research Report Information by Product (Shippers and Containers), by Type (Active System and Passive System), by Temperature Range (-20°C and Below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, and Above 25°C), by Payload Capacity (Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and Above 150 L), by Use (Single Use and Reusable), Medicine Type (Temperature Sensitive Pharmaceutical Drugs, Vaccine, and Regenerative Medicine), by End-use Industry (Pharmaceuticals and Clinical Trails), and by Region (North America, Europe, Asia Pacific, and Rest of the World) – Industry Forecast Till 2030
... and Above 25°C), by Payload Capacity (Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and Above 150 L), by Use (Single Use and Reusable), ... Read More
-
Biologics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Monooclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectius Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) According to our new research study ... Read More
-
Global Dengue Vaccine Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2030
... Segment Forecasts, 2023 – 2030 The Global Dengue Vaccine Market was valued around US $390.55 million in 2022 and is expected to reach US $1292.20 million by 2030 with a CAGR of 16.13% during the ... Read More
-
Asia Pacific Pneumococcal Vaccine Market Size study, by Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine) by Product (Prevnar 13, Synflorix, Pneumovax 23, Vaxneuvance, Pneumosil, Other Products) by End-use (Public Sector, Private Sector) and Country Forecasts 2022-2032
... Forecasts 2022-2032 Asia Pacific Pneumococcal Vaccine Market is valued approximately USD 1.02 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.17% over the forecast period 2024-2032. The ... Read More
-
Adult Bovine Serum Market by Origin (Australia-Sourced, New Zealand-Sourced, North America-Sourced), Application (Bioprocessing, Cell Culture, Vaccine Production), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 148.18 million in 2024, at a CAGR 5.61% to reach USD 205.99 million by 2030. Adult bovine serum (ABS) is an animal-derived serum extracted from the blood of adult ... Read More
-
Bioprocessing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
... (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & ... Read More
-
Bovine Mastitis Market, by Type (Clinical Mastitis and Sub-clinical Mastitis), by Product (Antibiotics, Vaccines, Pain Killers, and Others), by Route of Administration (Intra-mammary and Systemic), by Therapy (Lactating Period, Dry Period (Antibiotics, and Teat Sealants)), by End User (Veterinary Centers, Hospital, Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... by End User (Veterinary Centers, Hospital, Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031 Bovine mastitis ... Read More
-
IPV Vaccines Market, by Vaccine Brand (POLIOVAC (PFS/SD), SHANIPV, POLIORIX, IPOL/IMOVAX, And POLYMILEX), by Distribution Channel (Private and Public), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... Share, Outlook, and Opportunity Analysis, 2024 - 2031 Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. ... Read More
-
Cell Expansion Market, by Product (Consumables, (Media, Others), Instruments (Automated Cell, Expansion Systems, Cell Counters, Centrifuges, Bioreactors, Others), Accessories), by Cell Type (Mammalian Cells, (Human Cells, Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), Differentiated Cells, Animal Cells), Microbial Cells, Others (Plant-derived Cells)), by Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Cancer Research, Stem Cell Research, Other Applications), by End User (Biotechnology Companies, Biopharmaceutical Companies, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... Embryonic Stem Cells), Differentiated Cells, Animal Cells), Microbial Cells, Others (Plant-derived Cells)), by Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Cancer Research, Stem Cell Research, Other Applications), by End User (Biotechnology Companies, ... Read More
-
Influenza Vaccines Market, By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route of Administration (Injection, Nasal Spray), By Age Group (Paediatrics, Adults), By Technology (Egg-Based Flu Vaccines, Cell Culture-Based Flu Vaccines, Recombinant Flu Vaccines), By Distribution Channel (Public, Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Flu Vaccines), By Distribution Channel (Public, Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Global influenza vaccines market is estimated to be valued at USD 8.30 BN in 2024 ... Read More
-
Veterinary Vaccines Market, By Animal Type (Companion, Livestock), By Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, Subunit and DNA Vaccines, and Recombinant Vaccines), By Route of Administration (Subcutaneous Injection, Intramuscular Injection, Intranasal Administration, and Others), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Others), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Veterinary vaccines are biological preparations administered to animals in order to stimulate the immune system ... Read More
-
Nanomedicine Therapeutics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2030, Segmented By Indication (Oncology, Infectious Disease, Cardiology, Neurological Disease); By Application (Drug Delivery, Regenerative Medicine, Vaccines, Active Implants); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA))
... America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA)) Global Nanomedicine Therapeutics Market Size Booming at CAGR of 9.42% to Surpass Whopping USD 369 Billion by 2030 Global Nanomedicine Therapeutics Market ... Read More
-
Global Primary Cell Culture Market, By Product Type (Primary Cells, Instruments, Reagents and Supplements, Media, Other Consumables), By Cell Type (Human Primary Cells, Animal Primary Cells,), By Application (Cell & Gene Therapy Development, Vaccine Production, Drug Discovery and Development, Cancer Research, Prenatal Diagnosis, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Drug Discovery and Development, Cancer Research, Prenatal Diagnosis, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle ... Read More
-
Vaccine Adjuvant Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adjuvant Class (Mineral Salt Adjuvant, Emulsion Adjuvant, Liposome Adjuvant, and Others), Type (Human Vaccine Adjuvant and Veterinary Vaccine Adjuvant), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Adjuvant and Veterinary Vaccine Adjuvant), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) The vaccine adjuvants market is expected to grow from US$ 2.482 billion in 2022 ... Read More
-
Human Vaccine Adjuvants Market Size and Forecast (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Particulate Adjuvant, Emulsion Adjuvant, Combination Adjuvant, and Others), Application (Influenza, Hepatitis, Human papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) The global human ... Read More
-
Plant-based Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global plant-based vaccines market, which amassed revenues of US$ 1.6 billion in 2024, is expected to achieve a valuation of US$ 2.9 billion by the close of 2031. Plant-based vaccines have emerged as a promising ... Read More
-
West Nile Virus Market, By Product Type (Antivirals, Vaccines, Antibiotics, Analgesics, and Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Pacific, Latin America, Middle East, and Africa) West Nile virus (WNV) is a mosquito-borne disease that affects humans, birds, and other animals. It was first identified in the West Nile region of Uganda in 1937 ... Read More
-
Flu Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global Flu Vaccines Market displayed robust performance in 2024, with revenues reaching approximately US$ 5.7 billion. The market is projected to achieve a valuation of around US$ 10 billion by the end of 2031. Flu ... Read More
-
Autogenous Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global autogenous vaccines market is on a growth trajectory, with worldwide revenue reaching US$ 140 million in 2024. According to a recent analysis report, the market is projected reach US$ 220 million by the end ... Read More
-
Asia Pacific Veterinary Vaccines Market Report and Forecast 2024-2032
... between 2024 and 2032. Aided by the burgeoning demand for quality animal-derived products and the escalating significance of animal health, the market is expected to grow significantly by 2032. Veterinary vaccines play an indispensable role ... Read More
-
Viral Vector Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global viral vector vaccines market has exhibited impressive growth reaching a market size of US$ 780 million at the close of 2024, according to a recent study by Fairfield Market Research. The market is ... Read More
-
Viral Sensitizers Market by Application Area (Viral Vaccines, Oncolytic Viral Therapies, and Viral Vectors) and Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2023-2035
... valued at USD 481 million in 2023 growing at a CAGR of 14% during the forecast period 2023-2035. Viral sensitizers, synthetic small-molecule compounds, are incorporated into cell culture media to diminish the antiviral defenses within ... Read More
-
Biologics Contract Manufacturing Market by Type of Service Offered (API Manufacturing, FDF Manufacturing), Type of Biologic Manufactured (Antibodies, Cell Therapies, Vaccines and Other Biologics), Type of Expression System Used (Mammalian, Microbial and Others), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, 2023-2035
... Operation (Preclinical / Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global ... Read More
-
Autogenous Vaccine For Aquaculture Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) The global Autogenous Vaccine for Aquaculture Market is on a growth trajectory, with revenue reaching US$ 12.9 million in 2024. By the end of 2031, the market is expected to achieve a valuation of ... Read More
-
Synthetic Biology: Protein Design and Engineering Market- Focus on Services and Technology Providers – Market Distribution by Type of Protein Engineering Approach Used (Rational Designing, Directed Evolution and Semi-Rational Designing), Type of Protein (Antibodies, Peptides, Enzymes, Vaccines and Others), Type of Application (Therapeutics and Diagnostics), Type of End User (Pharma / Biotech Firms, CROs and Research / Academic Institutes) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa and Rest of the World)): Industry Trends and Global Forecasts, 2021-2035
... Enzymes, Vaccines and Others), Type of Application (Therapeutics and Diagnostics), Type of End User (Pharma / Biotech Firms, CROs and Research / Academic Institutes) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle ... Read More
Research Assistance
